Prologue Medicines
Prologue
Cambridge, United States · Founded 2021 · $50.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- prologuemedicines.com
- Total Funding
- $50.0M
- Last Round
- $50.0M Series AMay 2024
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.
About
Flagship Pioneering biotech exploring the viral proteome using machine learning to discover transformative medicines.
Summary
Prologue Medicines is a Biotech company based in Cambridge, United States, founded in 2021. It has raised $50.0M in total across 1 round, most recently a $50.0M Series A round in May 2024. Investors include Flagship Pioneering.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
May 2024
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/prologue-medicines"><img src="https://indexed.vc/api/badge/company/prologue-medicines" alt="Prologue Medicines on Indexed.vc" width="260" height="76" /></a>